Status:
UNKNOWN
Intratympanic Steroids for Sudden Hearing Loss
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. ...
Eligibility Criteria
Inclusion
- sudden hearing loss and initial treatment is not effective
Exclusion
- the patients refused intratympanic steroids treatment.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04129697
Start Date
January 1 2020
End Date
December 31 2022
Last Update
October 17 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.